ENTRY       D02979                      Drug
NAME        Ardenermin (USAN);
            BLyS (TN)
SEQUENCE    AVQGPEETVT QDCLQLIADS ETPTIQKGSY TFVPWLLSFK RGSALEEKEN KILVKETGYF
            FIYGQVLYTD KTYAMGHLIQ RKKVHVFGDE LSLVTLFRCI QNMPETLPNN SCYSAGIAKL
            EEGDELQLAI PRENAQISLD GDVTFFGALK LL
  TYPE      Peptide
EFFICACY    Antineoplastic
COMMENT     B cell survival factor that affects B cell representation and serum immunoglobulins in patients with congenital or acquired immunodeficiencis (tumor necrosis factor)
TARGET      TNFSF13B (BAFF, CD257) [HSA:10673] [KO:K05476]
  PATHWAY   hsa04064(10673)  NF-kappa B signaling pathway
BRITE       Target-based classification of drugs [BR:br08310]
             Cytokines and receptors
              Cytokines
               Tumor necrosis factors
                TNFSF13B (BAFF, CD257)
                 D02979  Ardenermin (USAN)
DBLINKS     CAS: 305391-49-5
            PubChem: 17397135
///
